Given its lower expression in tumor tissues than in adjacent normal tissues, strategies aimed at upregulating ULBP3 could be explored as a therapeutic approach to enhance the immune recognition and destruction of tumor cells. The gene discussed is ULBP3; the disease is neoplasm.